Investors

Events & presentations

Corporate presentations, conference posters and scientific talks, together with the webcasts of quarterly results and corporate update calls. Every document is available to download.

80 events from 2017 to 2025. 39 carry a downloadable presentation or poster: 40 files in total.

Webcast recordings are hosted by the conference or webcast provider and open in a new tab. Older recordings may have expired at source; the presentation files below do not expire, because they are served from this site.

Brainstorm Cell Therapeutics - Corporate Update

Listen to the webcast (opens in a new tab)

Presentation at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, May 6 - 10, 2025

Brainstorm Cell Therapeutics - Corporate Update

Listen to the webcast (opens in a new tab)

BrainStorm Cell Therapeutics KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Listen to the webcast (opens in a new tab)

Poster Presentations at the 2024 Annual NEALS Meeting October 21- 24, 2024

Investor Presentation - October 2024

Brainstorm Cell Therapeutics Second Quarter 2024 Earnings Call

Listen to the webcast (opens in a new tab)

Corporate Mid-Year Update on NurOwn Program

Listen to the webcast (opens in a new tab)

NurOwn Program Update Call Regarding Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Poster Presentation at the 2024 MDA Clinical and Scientific Conference

6th Annual ALS Research Symposium

Third Quarter 2023 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

Brainstorm Cell Therapeutics Investor Call

Listen to the webcast (opens in a new tab)

Second Quarter 2023 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

New biomarker data from the Phase 3 trial, presented at the Gordon Research Conference

First Quarter 2023 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

Brainstorm Investor Call

Listen to the webcast (opens in a new tab)

Poster Presentation at the 2023 MDA Clinical and Scientific Conference

13th Annual California ALS Research Summit

Biotech Showcase 2023

Third Quarter 2022 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

BrainStorm's Poster Presentation at the 21st Annual NEALS Meeting

Poster Presentation at ECTRIMS 2022

ALS One Research Symposium

Second Quarter 2022 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

CMSC 2022 Meeting

Listen to the webcast (opens in a new tab)

Poster Presentation at the ENCALS Meeting 2022, Edinburgh

Listen to the webcast (opens in a new tab)

ISEV 2022 Annual Meeting, Lyon France

Listen to the webcast (opens in a new tab)

ALS Drug Development Summit, Boston MA

Listen to the webcast (opens in a new tab)

First Quarter 2022 Financial Results and Corporate Update Call

Listen to the webcast (opens in a new tab)

ISCT 2022 Annual Meeting

Listen to the webcast (opens in a new tab)

BrainStorm Cell Therapeutics Announces Full Year 2021 Financial Results and Provides a Corporate Update

Listen to the webcast (opens in a new tab)

Presentation at the MDA Clinical and Scientific Conference

BrainStorm to Present at 12th Annual California ALS Research Summit

BrainStorm to Present New Biomarker Data on NurOwn at the 32nd International Symposium on ALS/MND

BrainStorm to Present at the 4th Annual ALS ONE Research Symposium

Brainstorm Cell Therapeutics Third Quarter 2021 Earnings Call

Listen to the webcast (opens in a new tab)

BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS

BrainStorm to Present ALS Phase 3 Biomarker Analyses at Annual NEALS Meeting

BrainStorm First Quarter 2021 Financial Results and Corporate Update

10th Annual SVB Leerink Global Healthcare Conference

Listen to the webcast (opens in a new tab)

BrainStorm-Cell Therapeutics Fourth Quarter and Fiscal Year 2020 Financial Results and Corporate Update

Listen to the webcast (opens in a new tab)

Annual Northeast ALS (NEALS) Meeting

WuXi Apptec- Collaborations That Transform Meeting (Multiple Sclerosis)

2020 CIRM Grantee Meeting

Advanced Therapies & Expo 2020

Listen to the webcast (opens in a new tab)

Canaccord Genuity 40th Annual Growth Conference

Listen to the webcast (opens in a new tab)

Financial Results for the Second Quarter of 2020 and Corporate Update

Listen to the webcast (opens in a new tab)

Company non-confidential Presentation August 2020

Key Opinion Leader (KOL) Webinar on the Company's Alzheimer's Disease (AD) Clinical Program

Raymond James Human Health Innovations Conference

Listen to the webcast (opens in a new tab)

Dr. Ralph Kern, MD, President and Chief Medical Officer, presents at Bio Digital 2020

Listen to the webcast (opens in a new tab)

Brainstorm Cell Therapeutics First Quarter 2020 Investor Earnings Call

Listen to the webcast (opens in a new tab)

BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19

Listen to the webcast (opens in a new tab)

BrainStorm Cell Therapeutics - Fourth Quarter 2019 Investor Earnings Call

Listen to the webcast (opens in a new tab)

BrainStorm CEO to Provide Company Update at the BIO CEO & Investor Conference

Listen to the webcast (opens in a new tab)

Dr. Ralph Kern at the ALS Research Forum, January 2020

Brainstorm Cell Therapeutics Presentation at the 2020 Biotech Showcase

Listen to the webcast (opens in a new tab)

Brainstorm Cell Therapeutics Presentation at the 3rd Annual Neuroscience Innovation Forum

Listen to the webcast (opens in a new tab)

BrainStorm Cell Therapeutics at the 2nd Annual Sachs Associates Neuroscience Innovation Forum

Listen to the webcast (opens in a new tab)

Brainstorm Cell Therapeutics Inc. 30th International Symposium on ALS/MND

Brainstorm Cell Therapeutics Inc. Third Quarter 2019 Business Update Conference Call

Listen to the webcast (opens in a new tab)

CEO Presentation at the Cell Series UK 2019 Conference

CFO Presentation at the Dawson James Conference 2019

Brainstorm Cell Therapeutics Inc. Second Quarter 2019 Business Update Conference Call

Listen to the webcast (opens in a new tab)

Brainstorm Cell Therapeutics presentation at the Bio International Convention

Brainstorm Cell Therapeutics Inc. at the 2019 CMSC Annual Meeting, Seattle WA

Brainstorm Cell Therapeutics presentation at the 12th Annual European Life Sciences CEO Forum

BrainStorm Cell Therapeutics presentations at the 37th Annual JP Morgan Healthcare Conference - 2019 Biotech Showcase

Listen to the webcast (opens in a new tab)

Presentation at the Biotech and Money Investival Showcase 2018

Brainstorm Presentation at the H.C. Wainwright & Co 20th Annual Investor Conference

BrainStorm Cell Therapeutics - Second Quarter 2018 Earnings Call

Listen to the webcast (opens in a new tab)

BrainStorm Cell Therapeutics - First Quarter 2018 Earnings Call

Listen to the webcast (opens in a new tab)

CEO's Presentation at the 2018 ARM Cell & Gene Investor Conference

Annual Financials Investor Call

CEO's Presentation at the 2018 Bio CEO & Investor Conference

CEO's Presentation at the 2018 Biotech Showcase Conference

Investor Presentation - September 2017

Investor Presentation October 2024 (alternate file)

Elsewhere

BrainStorm's autologous MSC-NTF cell therapy (NurOwn®, debamestrocel) is investigational and has not been approved by the FDA or any other regulatory authority.